These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29031980)

  • 1. Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo
    Lee AR; Kwon SY; Choi DH; Park ES
    Int J Pharm; 2017 Dec; 534(1-2):144-158. PubMed ID: 29031980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-by-design approach for the development of telmisartan potassium tablets.
    Oh GH; Park JH; Shin HW; Kim JE; Park YJ
    Drug Dev Ind Pharm; 2018 May; 44(5):837-848. PubMed ID: 29252038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QbD Consideration for Developing a Double-Layered Tablet into a Single-Layered Tablet with Telmisartan and Amlodipine.
    Kim JE; Park YJ
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.
    Kanwal U; Mukhtar S; Waheed M; Mehreen A; Abbas N; Shamim R; Hussain K; Rasool F; Hussain A; Bukhari NI
    Drug Des Devel Ther; 2021; 15():2193-2210. PubMed ID: 34079222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A formulation development strategy for dual-release bilayer tablets: An integrated approach of quality by design and a placebo layer.
    Han JK; Kim JY; Choi DH; Park ES
    Int J Pharm; 2022 Apr; 618():121659. PubMed ID: 35292397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either candesartan cilexetil or telmisartan.
    Belal TS; Mahrous MS; Abdel-Khalek MM; Daabees HG; Khamis MM
    Luminescence; 2014 Nov; 29(7):893-900. PubMed ID: 24615878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QbD-based development of an extraction procedure for simultaneous quantification of telmisartan, amlodipine besylate and chlorthalidone in combination complex matrix formulation.
    Palakurthi AK; Dongala T; Yalavarthi RK; Anireddy J
    Biomed Chromatogr; 2020 Feb; 34(2):e4755. PubMed ID: 31755118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
    Park J; Park HJ; Cho W; Cha KH; Yeon W; Kim MS; Kim JS; Hwang SJ
    Arch Pharm Res; 2011 Mar; 34(3):463-8. PubMed ID: 21547679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and bioequivalence of two Valsartan/Amlodipine immediate release tablets after a single oral administration.
    Zaid AN; Natur S; Qaddomi A; Abualhasan M; Al-Ramahi R; Shraim N; Khammash S; Jaradat N
    Pak J Pharm Sci; 2014 Jul; 27(4):755-62. PubMed ID: 25015436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate.
    Hadžidedić S; Uzunović A; Sehić Jazić S; Kocova El-Arini S
    Pharm Dev Technol; 2014 Dec; 19(8):930-41. PubMed ID: 24099553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method development and validation: quantitation of telmisartan bulk drug and its tablet formulation by
    Jadeja Y; Chomal B; Patel M; Jebaliya H; Khunt R; Shah A
    Magn Reson Chem; 2017 Jul; 55(7):634-638. PubMed ID: 27966230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of bilayer tablet manufacturing process for fixed dose combination of sustained release high-dose drug and immediate release low-dose drug based on quality by design (QbD).
    Won DH; Park H; Ha ES; Kim HH; Jang SW; Kim MS
    Int J Pharm; 2021 Aug; 605():120838. PubMed ID: 34197909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of stabilized tenofovir disoproxil tablet: degradation profile, stabilization, and bioequivalence in beagle dogs.
    Oh GH; Kim JE; Park YJ
    Drug Dev Ind Pharm; 2018 May; 44(5):757-766. PubMed ID: 29198140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
    Bejugam NK; Mutyam SK; Shankar GN
    Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of s-(-)-amlodipine besylate and nebivolol hydrochloride tablets.
    Shaikh SA; Shaikh SS; Shahi SR; Shookur MA; Reddy LK; Padalkar AN; Thube M
    J Adv Pharm Technol Res; 2010 Apr; 1(2):199-206. PubMed ID: 22247846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.